120 related articles for article (PubMed ID: 38678611)
1. Bioinformatics-based analysis of potential therapeutic target genes for polycystic ovary syndrome.
Liu Y; Yu J; Li J; Li W; Ma H
Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):169-175. PubMed ID: 38678611
[TBL] [Abstract][Full Text] [Related]
2. Identification of key pathways and genes in polycystic ovary syndrome via integrated bioinformatics analysis and prediction of small therapeutic molecules.
Devarbhavi P; Telang L; Vastrad B; Tengli A; Vastrad C; Kotturshetti I
Reprod Biol Endocrinol; 2021 Feb; 19(1):31. PubMed ID: 33622336
[TBL] [Abstract][Full Text] [Related]
3. Identification of Hub Genes and Biomarkers between Hyperandrogen and Normoandrogen Polycystic Ovary Syndrome by Bioinformatics Analysis.
Zhang T; Liu Y; Li X; Hu B
Comb Chem High Throughput Screen; 2023; 26(1):126-134. PubMed ID: 35379124
[TBL] [Abstract][Full Text] [Related]
4. Integrated analysis of DNA methylation and transcriptome profiling of polycystic ovary syndrome.
Liu L; He D; Wang Y; Sheng M
Mol Med Rep; 2020 May; 21(5):2138-2150. PubMed ID: 32323770
[TBL] [Abstract][Full Text] [Related]
5. Screening and validation of potential markers associated with uterine corpus endometrial carcinoma and polycystic ovary syndrome based on bioinformatics methods.
Wu R; Wu C; Zhu B; Li J; Zhao W
Front Mol Biosci; 2023; 10():1192313. PubMed ID: 37363398
[No Abstract] [Full Text] [Related]
6. Microarray analysis of obese women with polycystic ovary syndrome for key gene screening, key pathway identification and drug prediction.
Wei L; Xin C; Wang W; Hao C
Gene; 2018 Jun; 661():85-94. PubMed ID: 29601948
[TBL] [Abstract][Full Text] [Related]
7. Identification of the key pathways and genes related to polycystic ovary syndrome using bioinformatics analysis.
Bi X; Zhai Z; Wang S
Gen Physiol Biophys; 2019 May; 38(3):205-214. PubMed ID: 31184307
[TBL] [Abstract][Full Text] [Related]
8. Integrated bioinformatics and network pharmacology to explore the therapeutic target and molecular mechanisms of Bailing capsule on polycystic ovary syndrome.
Guan HR; Li B; Zhang ZH; Wu HS; He XL; Dong YJ; Su J; Lv GY; Chen SH
BMC Complement Med Ther; 2023 Dec; 23(1):458. PubMed ID: 38102584
[TBL] [Abstract][Full Text] [Related]
9. Integrative Analysis of Core Genes and Biological Process Involved in Polycystic Ovary Syndrome.
Zhang Y; Zhao T; Hu L; Xue J
Reprod Sci; 2023 Oct; 30(10):3055-3070. PubMed ID: 37171773
[TBL] [Abstract][Full Text] [Related]
10. Identification of key genes and miRNAs related to polycystic ovary syndrome by comprehensive analysis of microarray.
Sun Z; Wang Y; Wei T; Liu L
BMC Med Genomics; 2022 Dec; 15(1):267. PubMed ID: 36544152
[TBL] [Abstract][Full Text] [Related]
11. Exploration of hub genes involved in PCOS using biological informatics methods.
Zhou F; Xing Y; Cheng T; Yang L; Ma H
Medicine (Baltimore); 2022 Oct; 101(40):e30905. PubMed ID: 36221354
[TBL] [Abstract][Full Text] [Related]
12. Bioinformatics identification of microRNAs involved in polycystic ovary syndrome based on microarray data.
Hou Y; Wang Y; Xu S; Qi G; Wu X
Mol Med Rep; 2019 Jul; 20(1):281-291. PubMed ID: 31115532
[TBL] [Abstract][Full Text] [Related]
13. Unveiling Key Biomarkers and Therapeutic Drugs in Polycystic Ovary Syndrome (PCOS) Through Pathway Enrichment Analysis and Hub Gene-miRNA Networks.
Heidarzadehpilehrood R; Pirhoushiaran M; Binti Osman M; Ling KH; Abdul Hamid H
Iran J Pharm Res; 2023; 22(1):e139985. PubMed ID: 38444712
[TBL] [Abstract][Full Text] [Related]
14. Pathway and network-based analysis of genome-wide association studies and RT-PCR validation in polycystic ovary syndrome.
Shen H; Liang Z; Zheng S; Li X
Int J Mol Med; 2017 Nov; 40(5):1385-1396. PubMed ID: 28949383
[TBL] [Abstract][Full Text] [Related]
15. Identification of Crucial lncRNAs, miRNAs, mRNAs, and Potential Therapeutic Compounds for Polycystic Ovary Syndrome by Bioinformatics Analysis.
Zeng Z; Lin X; Xia T; Liu W; Tian X; Li M
Biomed Res Int; 2020; 2020():1817094. PubMed ID: 33224973
[TBL] [Abstract][Full Text] [Related]
16. Integrated bioinformatics analysis and screening of hub genes in polycystic ovary syndrome.
Qiao G; Xing J; Luo X; Zhang C; Yi J
Endocrine; 2022 Dec; 78(3):615-627. PubMed ID: 36068422
[TBL] [Abstract][Full Text] [Related]
17. Identification of Key Genes and Imbalanced SNAREs Assembly in the Comorbidity of Polycystic Ovary Syndrome and Depression.
Cao Y; Wang W; Song X; Wen Q; Xie J; Zhang D
Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674428
[TBL] [Abstract][Full Text] [Related]
18. Characterization of circular RNA expression profiles in cumulus cells from patients with polycystic ovary syndrome.
Che Q; Liu M; Xu J; Liu Y; Cao X; Dong X; Liu S
Fertil Steril; 2019 Jun; 111(6):1243-1251.e1. PubMed ID: 30979425
[TBL] [Abstract][Full Text] [Related]
19. Construction of a competing endogenous RNA network to identify drug targets against polycystic ovary syndrome.
Wu T; Gao YY; Tang XN; Li Y; Dai J; Zhou S; Wu M; Zhang JJ; Wang SX
Hum Reprod; 2022 Nov; 37(12):2856-2866. PubMed ID: 36223608
[TBL] [Abstract][Full Text] [Related]
20. Integrated miRNA-mRNA Expression Profiles Revealing Key Molecules in Ovarian Cancer Based on Bioinformatics Analysis.
Li C; Hong Z; Ou M; Zhu X; Zhang L; Yang X
Biomed Res Int; 2021; 2021():6673655. PubMed ID: 34734085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
